
Veronica Rendo
@veronica_rendo
Group Leader, Uppsala University 🇸🇪 | Brain tumor evolution and treatment resistance
ID: 937269287621971968
03-12-2017 10:36:26
197 Tweet
249 Takipçi
547 Takip Edilen




In a new “window-of-opportunity” trial of patients with #glioblastoma, researchers characterize the therapeutic effects of the MDM2 inhibitor #navtemadlin and reveal potential mechanisms of resistance. Rameen Beroukhim Veronica Rendo Dana-Farber scim.ag/4i8zBeV




Recently published in Science Magazine: A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma. Learn more 👉science.org/doi/10.1126/sc… #EANOessentials #NeuroOncology #Glioma #btsm



